The Cloudpharm Team participated in CPHI Milan 2024, showcasing innovations from the ENVIROMED project on greener, sustainable-by-design pharmaceuticals. The event offered an excellent opportunity to connect with industry leaders, explore the latest advances in...
Cloudpharm, honored as a Top 10 Drug Discovery and Development Solutions Provider in Europe for 2023, leads in computational approaches for pharmaceutical advancements. Featured in the latest Life Sciences Review, our mission emphasizes innovation in identifying...
The conference “Dietary Supplements for Osteoporosis: OSTEOME Study” was successfully completed on Wednesday, December 20, 2023. In the amphitheater “GEORGIOS P. LYRITIS” at the Laboratory for Research on Musculoskeletal Disorders,...
Our “one-stop-shop” next generation drug repurposing platform (Cloudscreen) was presented in the drug repurposing event organized by REPO4EU in Athens. Our collaborator from National Hellenic Research Foundation, Dr. Theodora Katsila presented the key features of our...
Cloudpharm’s team members visited the University of Bari Aldo Moro in January to attend the partner meeting and training workshop in the framework of the European Project #Neghtra. Next Generation Training on Intelligent Greenhouses (NEGHTRA) aims to provide...
